| Financial Year |
March 31 2023 |
| Monetary Funds |
1,076,171,979.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
352,361.65 |
| Advances to Suppliers |
5,315,843.86 |
| Other Receivables |
511,520.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,572,911.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
87,382,802.43 |
| Total Current Assets |
1,192,341,819.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
567,143.03 |
| Investment Properties |
25,809,154.31 |
| Fixed Assetes |
137,126,840.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
23,725,997.32 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,093,577.26 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
189,328,999.93 |
| Total Assets |
1,381,670,819.68 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
87,484,540.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,688,940.15 |
| Taxes Payable |
634,928.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,096,144.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,766.66 |
| Other Current Liabilities |
1,863,773.40 |
| Sub-Total of Current Liabilities |
132,113,811.74 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,937,497.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,937,497.78 |
| Total Liabilities |
134,051,309.52 |
| Paid-In Capital(Or Share Stock) |
680,319,676.00 |
| Capital Surplus |
1,645,312,920.48 |
| Surplus Reserve |
89,015,542.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,295,663,266.06 |
| Minority Stockholder's Interest |
127,244,572.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,120,374,937.99 |
| Owner's Equity（Stockholder's Equity） |
1,247,619,510.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,381,670,819.68 |
